Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 166

1.

Synergistic antiemetic interactions between serotonergic 5-HT3 and tachykininergic NK1-receptor antagonists in the least shrew (Cryptotis parva).

Darmani NA, Chebolu S, Amos B, Alkam T.

Pharmacol Biochem Behav. 2011 Oct;99(4):573-9. doi: 10.1016/j.pbb.2011.05.025.

PMID:
21683089
3.

Utilization of the least shrew as a rapid and selective screening model for the antiemetic potential and brain penetration of substance P and NK1 receptor antagonists.

Darmani NA, Wang Y, Abad J, Ray AP, Thrush GR, Ramirez J.

Brain Res. 2008 Jun 12;1214:58-72. doi: 10.1016/j.brainres.2008.03.077.

4.

Broad-spectrum antiemetic efficacy of the L-type calcium channel blocker amlodipine in the least shrew (Cryptotis parva).

Zhong W, Chebolu S, Darmani NA.

Pharmacol Biochem Behav. 2014 May;120:124-32. doi: 10.1016/j.pbb.2014.03.005.

PMID:
24631485
7.

Probable involvement of the 5-hydroxytryptamine(4) receptor in methotrexate-induced delayed emesis in dogs.

Yamakuni H, Sawai H, Maeda Y, Imazumi K, Sakuma H, Matsuo M, Mutoh S, Seki J.

J Pharmacol Exp Ther. 2000 Mar;292(3):1002-7.

8.

The antiemetic 5-HT3 receptor antagonist Palonosetron inhibits substance P-mediated responses in vitro and in vivo.

Rojas C, Li Y, Zhang J, Stathis M, Alt J, Thomas AG, Cantoreggi S, Sebastiani S, Pietra C, Slusher BS.

J Pharmacol Exp Ther. 2010 Nov;335(2):362-8. doi: 10.1124/jpet.110.166181.

9.

Additive antiemetic efficacy of low-doses of the cannabinoid CB(1/2) receptor agonist Δ(9)-THC with ultralow-doses of the vanilloid TRPV1 receptor agonist resiniferatoxin in the least shrew (Cryptotis parva).

Darmani NA, Chebolu S, Zhong W, Trinh C, McClanahan B, Brar RS.

Eur J Pharmacol. 2014 Jan 5;722:147-55. doi: 10.1016/j.ejphar.2013.08.051.

PMID:
24157976
10.
12.

Differential involvement of neurotransmitters through the time course of cisplatin-induced emesis as revealed by therapy with specific receptor antagonists.

Hesketh PJ, Van Belle S, Aapro M, Tattersall FD, Naylor RJ, Hargreaves R, Carides AD, Evans JK, Horgan KJ.

Eur J Cancer. 2003 May;39(8):1074-80.

PMID:
12736106
13.
14.

Pharmacological mechanisms of 5-HT₃ and tachykinin NK₁ receptor antagonism to prevent chemotherapy-induced nausea and vomiting.

Rojas C, Slusher BS.

Eur J Pharmacol. 2012 Jun 5;684(1-3):1-7. doi: 10.1016/j.ejphar.2012.01.046. Review.

PMID:
22425650
15.

Inhibition of substance P-mediated responses in NG108-15 cells by netupitant and palonosetron exhibit synergistic effects.

Stathis M, Pietra C, Rojas C, Slusher BS.

Eur J Pharmacol. 2012 Aug 15;689(1-3):25-30. doi: 10.1016/j.ejphar.2012.05.037.

PMID:
22683863
16.

Effects of CP-99, 994, a tachykinin NK(1) receptor antagonist, on abdominal afferent vagal activity in ferrets: evidence for involvement of NK(1) and 5-HT(3) receptors.

Minami M, Endo T, Yokota H, Ogawa T, Nemoto M, Hamaue N, Hirafuji M, Yoshioka M, Nagahisa A, Andrews PL.

Eur J Pharmacol. 2001 Oct 5;428(2):215-20.

PMID:
11675038
17.

Molecular mechanisms of 5-HT(3) and NK(1) receptor antagonists in prevention of emesis.

Rojas C, Raje M, Tsukamoto T, Slusher BS.

Eur J Pharmacol. 2014 Jan 5;722:26-37. doi: 10.1016/j.ejphar.2013.08.049. Review.

PMID:
24184669
18.

Antiemetic effects of sendide, a peptide tachykinin NK1 receptor antagonist, in the ferret.

Minami M, Endo T, Kikuchi K, Ihira E, Hirafuji M, Hamaue N, Monma Y, Sakurada T, Tan-no K, Kisara K.

Eur J Pharmacol. 1998 Dec 11;363(1):49-55.

PMID:
9877081
19.

The anti-emetic effects of CP-99,994 in the ferret and the dog: role of the NK1 receptor.

Watson JW, Gonsalves SF, Fossa AA, McLean S, Seeger T, Obach S, Andrews PL.

Br J Pharmacol. 1995 May;115(1):84-94.

20.
Items per page

Supplemental Content

Support Center